ECR 2013 – Final Programme - myESR.org

Scientific SessionsB-0427 – B-044615:03B-0427 High-intensity focused ultrasound ablation ofpancreatic cancer: a totally non-invasive treatmentfor tumour control of locally advanced lesions (stageIII)F. Zaccagna, A. Napoli, G. Cartocci, G. Brachetti, L. DI Mare, F. Boni, V. Noce,L. Bertaccini, C. Catalano; Rome/IT15:12B-0428 Fusion imaging-guided percutaneous biopsy of focalhepatic lesions with poor conspicuity on conventionalultrasonographyH. Park, M. Lee, M. Kim, M. Lee, J. Hwang, T. Kang, S. Lim, H. Lim, H. Lim;Seoul/KR15:21B-0429 CTNAV: a prospective randomised clinical trial of anavigation system for computer assisted CT guidedinterventionsP. Durand, A. Moreau-Gaudry, J. Frandon, M. Medici, E. Chipon, C. Sengel,I. Bricault; Grenoble/FR14:00–15:30 Room E1MusculoskeletalSS 610a Musculoskeletal tumoursModerators: E. Quaia; Trieste/IT, R. Lalam; Oswestry/UK14:00B-0430 Magnetic resonance imaging parameters predictive formalignancy: a prospective study of 100 consecutivesoft-tissue musculoskeletal massesV. Vasilevska Nikodinovska, M. Samargiski, V. Janevska, S. K.Kunovska;Skopje/MK14:09B-0431 Evaluation of features and role of ultrasound andMR imaging in large lipomas and well-differentiatedliposarcomasH. Gupta 1 , V. Bhat 2 , S. Edward 1 , E. Hensor 1 , P. Robinson 1 ; 1 Leeds/UK, 2 Cardiff/UK14:18B-0432 Comparison of efficacy of surgical-, CT- and PET-CTguidedbiopsy in musculoskeletal lesionsJ.L.M.A. Gielen, A.M. De Schepper, S. Ceyssens, D.H. Creytens, J. Somville, P. VanDyck, P. Pauwels, M. Peeters, P.M. Parizel; Antwerp/BE14:27B-0433 CT evaluation of thoracic bone metastasis: comparisonof 3D volume-rendered images and combined axialand coronal multiplanar reconstruction imagesK. Doo 1 , E.-Y. Kang 1 , H. Yong 1 , O. Woo 1 , K. Lee 2 , Y.-W. Oh 1 ; 1 Seoul/KR, 2 Ansan/KR14:36B-0434 DCE-MRI for assessment of vessel remodellingassociated with bone defect healing in experimentallytic bone metastasesD. Komljenovic, W. Semmler, T. Bäuerle; Heidelberg/DE14:45B-0435 View-angle tilting (VAT) and slice-encoding metalartifact correction (SEMAC) for MR imaging oforthopaedic tumor prosthesesP.M. Jungmann 1 , C. Ganter 1 , F. Pohlig 1 , C. Schaeffeler 1 , J.S. Bauer 1 , M. Nittka 2 ,E.J. Rummeny 1 , H. Rechl 1 , K. Woertler 1 ; 1 Munich/DE, 2 Erlangen/DE14:54B-0436 Association of QCT bone mineral density and bonestructure with vertebral fractures in patients withmultiple myelomaJ. Borggrefe 1 , S. Giravent 2 , F. Thomsen 2 , J. Peña 2 , A. Wulff 2 , A. Günther 1 ,M. Heller 2 , C.C. Glüer 1 ; 1 Cologne/DE, 2 Kiel/DE15:03B-0437 Imaging patterns in multiple myeloma: observationsat whole body MRIN.M. Long, O.M. Drumm, P. O‘ Gorman, S.J. Eustace; Dublin/IE15:12B-0438 Efficacy of whole body low-dose CT (WBLDCT) in thestaging of patients with early multiple myeloma:comparison with whole body magnetic resonanceimaging (WBMRI)V. Besostri, D. Ippolito, P.A. Bonaffini, A. Masetto, A. Cuccia, S. Sironi; Milan/IT15:21B-0439 Role of apparent diffusion coefficient (ADC) maps inthe evaluation of tumour response in chemotherapy inpatients with multiple myelomaP.A. Bonaffini, D. Ippolito, V. Besostri, A. Casiraghi, A. Di Lelio, S. Sironi; Monza/IT14:00–15:30 Room F1Abdominal VisceraSS 601 Liver steatosis: imaging andquantificationModerators: I. Bargellini; Pisa/IT, B. Van Beers; Clichy/FR14:00B-0440 Presence/absence of hepatic steatosis afterpercutaneous intraportal pancreatic islettransplantation in 108 allo- and auto-transplantedpatients: can ultrasound predict the clinical outcome?G. Agostini, M. Venturini, G. Querques, P. Maffi, C. Gremizzi, A. Palmisano, F. DeCobelli, A. Secchi, A. Del Maschio; Milan/IT14:09B-0441 Phosphorus magnetic resonance spectroscopy(31P-MRS) in non-alcoholic fatty liver disease(NAFLD)J.M. Abrigo, V.-S. Wong, D.-W. Yeung, G.-H. Wong, A.-h. Chan, H.-Y. Chan, W.-W. Chu; Shatin/HK14:18B-0442 Clinical implications of fatty liver on hepatic diffusionweightedimaging studied in healthy subjectsH. Dijkstra, A. Handayani, P. Kappert, M. Oudkerk, P.E. Sijens; Groningen/NL14:27B-0443 Liver fat volume fraction quantification in patientswith chronic liver diseases with separated estimationof fat and water relaxation times at 1.5 and 3.0TB. Leporq, F. Pilleul, O. Beuf; Villeurbanne/FR14:36B-0444 Combination of liver intravoxel incoherent motionimaging with MR fat quantification at 3.0T todistinguish between pure steatosis and NASHB. Leporq 1 , F. Pilleul 1 , J. Dumortier 2 , O. Guillaud 2 , T. Lefort 2 , O. Beuf 1 ;1Villeurbanne/FR, 2 Lyon/FR14:45B-0445 Quantification of steatosis hepatitis and liver ironoverload in a population-based study using magneticresonance imagingJ.P. Kühn 1 , D. Hernando 2 , H. Völzke 1 , S.B. Reeder 2 , N. Hosten 1 , B. Mensel 1 ,K. Hegenscheid 1 , M. Evert 1 , S. Baumeister 1 ; 1 Greifswald/DE, 2 Madison, WI/US14:54B-0446 Effect of Gd-EOB-DTPA on hepatic fat quantificationusing high-speed T2-corrected multiecho acquisition(HISTO) at 1H MR spectroscopyY. Park 1 , C. Lee 1 , I. Kim 1 , B. Kiefer 2 , K. Kim 1 , J. Choi 1 , J. Lee 1 , C. Park 1 ; 1 Seoul/KR,2Erlangen/DE236